what are the Recommendations for Mineralocorticoid Receptor Antagonists (MRAs)
Referenced studies that support the recommendations are summa-
rized in the Online Data Supplements.?
In patients taking MRA whose serum potas- sium cannot be maintained at <5.5 mEq/L, MRA should be discontinued to avoid life- threatening hyperkalemia.